NRAS and melanoma: The most common genetic targets, BRAF and NRAS, are frequently mutated in nearly 50% and 20% melanomas, respectively 11, which result in hyperactivation of MAPK and PI3K pathways and subsequent uncontrolled proliferation of melanoma cells 6, 12.